Sylvia M Dobo Selected Research

berotralstat

6/2021	Long-term safety and effectiveness of berotralstat for hereditary angioedema: The open-label APeX-S study.
1/2021	Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial.
1/2021	Oral berotralstat for the prophylaxis of hereditary angioedema attacks in patients in Japan: A phase 3 randomized trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sylvia M Dobo Research Topics

Disease

3	Hereditary Angioedemas 06/2021 - 01/2021
2	Angioedema 06/2021 - 01/2021
2	Abdominal Pain (Pain, Abdominal) 01/2021 - 01/2021
2	Diarrhea 01/2021 - 01/2021
1	Vomiting 01/2021
1	Cough 01/2021
1	Back Pain (Backache) 01/2021
1	Fever (Fevers) 01/2021
1	Nasopharyngitis 01/2021

Drug/Important Bio-Agent (IBA)

3	berotralstatIBA 06/2021 - 01/2021
3	Plasma KallikreinIBA 06/2021 - 01/2021

Therapy/Procedure

1	Therapeutics 01/2021